KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Other Working Capital Changes (2016 - 2025)

Acadia Pharmaceuticals has reported Other Working Capital Changes over the past 16 years, most recently at -$11.7 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$11.7 million for Q4 2025, up 41.65% from a year ago — trailing twelve months through Dec 2025 was -$6.5 million (up 14.24% YoY), and the annual figure for FY2025 was -$6.5 million, up 14.24%.
  • Other Working Capital Changes for Q4 2025 was -$11.7 million at Acadia Pharmaceuticals, down from $3.9 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for ACAD hit a ceiling of $19.9 million in Q3 2023 and a floor of -$22.4 million in Q4 2023.
  • Median Other Working Capital Changes over the past 5 years was -$1.2 million (2021), compared with a mean of -$1.4 million.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 21070.0% in 2022 and later skyrocketed 2312.9% in 2023.
  • Acadia Pharmaceuticals' Other Working Capital Changes stood at -$4.4 million in 2021, then soared by 63.43% to -$1.6 million in 2022, then tumbled by 1305.89% to -$22.4 million in 2023, then increased by 10.56% to -$20.1 million in 2024, then soared by 41.65% to -$11.7 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$11.7 million (Q4 2025), $3.9 million (Q3 2025), and $937000.0 (Q2 2025) per Business Quant data.